Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper

T Marjot, CS Eberhardt, T Boettler, LS Belli… - Journal of …, 2022 - Elsevier
The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …

The role of B cells in COVID-19 infection and vaccination

S Chen, F Guan, F Candotti, K Benlagha… - Frontiers in …, 2022 - frontiersin.org
B cells secrete antibodies and mediate the humoral immune response, making them
extremely important in protective immunity against SARS-CoV-2, which caused the …

[PDF][PDF] Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19

JP Bernardes, N Mishra, F Tran, T Bahmer, L Best… - Immunity, 2020 - cell.com
Temporal resolution of cellular features associated with a severe COVID-19 disease
trajectory is needed for understanding skewed immune responses and defining predictors of …

COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease

R Fernandez-Ruiz, JL Paredes, TB Niewold - Translational Research, 2021 - Elsevier
As the world navigates the coronavirus disease 2019 (COVID-19) pandemic, there is a
growing need to assess its impact in patients with autoimmune rheumatic diseases, such as …

Molecular mimicry and autoimmunity in the time of COVID-19

M Rojas, M Herrán, C Ramírez-Santana… - Journal of …, 2023 - Elsevier
Infectious diseases are commonly implicated as potential initiators of autoimmune diseases
(ADs) and represent the most commonly known factor in the development of autoimmunity in …

COVID-19 and the brain

KS Hingorani, S Bhadola… - Trends in cardiovascular …, 2022 - Elsevier
Entering the third year into the pandemic, overwhelming evidence demonstrates that
Coronavirus disease 2019 (COVID-19) infection is a systemic illness, often with involvement …

[PDF][PDF] Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses

CM Buckner, L Kardava, O El Merhebi, SR Narpala… - Cell, 2022 - cell.com
SARS-CoV-2 mRNA booster vaccines provide protection from severe disease, eliciting
strong immunity that is further boosted by previous infection. However, it is unclear whether …

SARS-CoV-2 vaccine induced atypical immune responses in antibody defects: everybody does their best

AF Salinas, EP Mortari, S Terreri, C Quintarelli… - Journal of clinical …, 2021 - Springer
Background Data on immune responses to SARS-CoV-2 in patients with Primary Antibody
Deficiencies (PAD) are limited to infected patients and to heterogeneous cohorts after …

Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications

Y Ye, Z Chen, S Jiang, F Jia, T Li, X Lu, J Xue… - Nature …, 2022 - nature.com
Anti-melanoma differentiation-associated gene 5-positive dermatomyositis (MDA5+ DM) is
an autoimmune condition associated with rapidly progressive interstitial lung disease and …

Time of day influences immune response to an inactivated vaccine against SARS-CoV-2

H Zhang, Y Liu, D Liu, Q Zeng, L Li, Q Zhou, M Li, J Mei… - Cell research, 2021 - nature.com
Dear Editor, The coronavirus disease 2019 (COVID-19) pandemic that caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people and …